Raytam Pharmaceutical Company
Standard Operating Procedure
Inspired by the Integrity and Strength of the Rafflesia schadenbergiana Flower
Unit 1 Check-in Post-Task
PHCARE 202 Basic Dispensing 1
SOP # PHC-202-SOP-01
Version # 1
Dispensing of Effective Date February 27, 2026
Prescription Drugs
Page # 1 of 3 Last Reviewed/ February 27, 2026
Updated
Standard Operating Procedure
1. PURPOSE AND SCOPE
1.0 Purpose
1.1 To ensure prescription medicines are dispensed accurately, safely, and legally
under the supervision of a duly licensed pharmacist.
1.2 To comply with RA 6675 (Generics Act) by ensuring generic name use in
dispensing, offering equivalent options, and minimizing duplication/medication
errors.
1.3 To uphold RA 10918 (Philippine Pharmacy Act) requiring pharmacist
supervision for dispensing of prescription medicines.
2.0 Scope
2.1 Applies to Category A pharmaceutical establishments/outlets where direct
pharmacist supervision is required (RA 10918).
2.2 Applies to licensed pharmacists; pharmacy assistants may assist only under
direct supervision.
2.3 Covers dispensing of all prescription/ethical medicines, including
pharmacist-only OTC medicines when applicable to Category A operations.
2. DETAILED PROCEDURE
3.0 Reception and Validation
3.1 Receive the prescription and identify the patient (full name; confirm age/address
when needed).
3.2 Validate prescription completeness and legitimacy:
3.2.1 Date of prescription
3.2.2 Patient details (name, age, address)
3.2.3 Medicine details (drug, strength, dosage form, quantity, directions)
3.2.4 Prescriber details (name, clinic address/contact, PRC/license identifiers, PTR
if required by local standards), signature
3.3 Screen for tampering/alterations or unusual requests; if suspicious, hold
dispensing and proceed to clarification/referral (see 4.4).
3.4 If the patient is a senior citizen requesting a discount: require proof of eligibility
(e.g., OSCA ID/passport) and ensure prescription is available (RA 9994 rules: Rx
required except OTC).
4.0 Interpretation
4.1 Interpret drug order (dose, frequency, duration) and assess appropriateness.
4.2 Apply Generics Act principles (RA 6675):
4.2.1 Ensure the generic name is recognized/used in dispensing records and
counseling.
4.2.2 If brand is written, ensure the patient is informed of available products with the
same generic name (equivalent options).
4.3 Perform clinical screening: allergies, contraindications, duplication (same
generic), interactions.
4.4 Clarify unclear/unsafe orders with prescriber before preparation (document the
intervention).
5.0 Preparation and Labeling
5.1 Select product using generic-first verification (match generic name, then
strength and dosage form).
5.2 Verify packaging integrity and check expiry date and lot/batch number.
5.3 Prepare the correct quantity using appropriate counting/measuring technique.
5.4 Label the dispensed medicine accurately. Minimum label content:
5.4.1 Patient name
5.4.2 Generic name (and brand name if necessary for identification)
5.4.3 Strength, dosage form
5.4.4 Directions for use (clear and patient-friendly)
5.4.5 Quantity
5.4.6 Date dispensed and pharmacy identifiers
5.4.7 Auxiliary warnings as applicable
6.0 Final Checking
6.1 Conduct final verification using “right patient–right drug–right dose–right
route–right time–right labeling–right quantity.”
6.2 Confirm generic equivalence when substitution/options were discussed.
6.3 If senior discount applies, verify documentary requirements and compute
correctly (VAT-exempt then 20% discount if VAT-registered; RA 9994 guidance).
7.0 Recording and Documentation
7.1 Record dispensing details in the prescription log/e-system including:
7.1.1 Patient name (and senior ID reference if used)
7.1.2 Drug generic name, strength, dosage form, quantity
7.1.3 Prescriber identifiers
7.1.4 Date dispensed, pharmacist initials/signature
7.2 For senior citizen transactions: issue official receipt reflecting retail price and
discounted price; comply with required recording (purchase booklet if used per
institutional policy).
8.0 Patient Counseling and Dispensing
8.1 Provide counseling emphasizing: indication, dose schedule, duration, missed
dose advice, key adverse effects, storage.
8.2 Reinforce generic name awareness (RA 6675) to prevent duplication with other
brands.
8.3 Dispense medicine only after the patient confirms understanding; encourage
return/consult if adverse effects occur.
3. DOCUMENTATION AND RECORDING
9.1 Prescription logbook/electronic record retained per pharmacy policy.
9.2 Intervention/clarification notes (if any).
9.3 Senior citizen discount documentation: proof presented + receipt details
retained.
4. REVIEW AND APPROVAL
Prepared by: Approved by:
Muhammad Raffi T. Gadi Juanito Carlo VI Deita, RPh, PharmD
SOP # PHC-202-SOP-0
2
Version # 1
Dispensing of
Over-the-Counter Effective Date February 27,
(OTC) Drugs 2026
Page # 1 of 2 Last Reviewed/ February 27,
Updated 2026
Standard Operating Procedure
1. PURPOSE AND SCOPE
1.0 Purpose
To ensure rational, safe, and appropriate dispensing of OTC medications.
2.0 Scope
Applies to pharmacists and supervised pharmacy assistants handling OTC
products.
2. RESPONSIBILITIES
3.0 Reception and Validation
3.1 Receive patient request or symptom inquiry.
3.2 Conduct brief patient assessment:
● Symptoms
● Duration
● Current medications
● Allergies
● Medical conditions
4.0 Interpretation
4.1 Determine if condition is self-limiting.
4.2 Identify red flag symptoms requiring referral.
4.3 Select appropriate OTC therapy.
5.0 Preparation and Labeling
5.1 Retrieve correct product.
5.2 Verify expiration date.
5.3 Attach additional instructions if needed.
6.0 Final Checking
6.1 Confirm correct product.
6.2 Reassess appropriateness.
7.0 Recording and Documentation
7.1 Document pharmacist recommendation (if required).
7.2 Record adverse events if reported.
8.0 Patient Counseling and Dispensing
8.1 Explain:
● Proper dosage
● Duration
● Side effects
● When to seek medical help
8.2 Dispense product.
3. DOCUMENTATION AND RECORDING
9.0 OTC recommendation log (if applicable)
9.1 Incident documentation for adverse reactions
5. REVIEW AND APPROVAL
Prepared by: Approved by:
Muhammad Raffi T. Gadi Juanito Carlo VI Deita, RPh, PharmD
SOP # PHC-202-SOP-0
3
Version # 1
Dispensing of
Dietary and Food Effective Date February 27,
Supplements 2026
Page # 1 of 2 Last Reviewed/ February 27,
Updated 2026
Standard Operating Procedure
1. PURPOSE AND SCOPE
1.0 Purpose
To ensure safe dispensing and appropriate counseling of dietary supplements.
2.0 Scope
Applies to all pharmacy personnel involved in supplement dispensing.
2. RESPONSIBILITIES
3.0 Reception and Validation
3.1 Receive request.
3.2 Assess:
● Intended use
● Existing conditions
● Current medications
4.0 Interpretation
4.1 Check for potential drug-supplement interactions.
4.2 Verify product registration (FDA compliant).
5.0 Preparation and Labeling
5.1 Verify expiration and integrity.
5.2 Attach usage instructions if needed.
6.0 Final Checking
6.1 Confirm correct product and dosage.
7.0 Recording and Documentation
7.1 Document recommendation if clinically significant.
7.2 Record adverse reactions when reported.
8.0 Patient Counseling and Dispensing
8.1 Explain:
● Intended benefit
● Proper dosage
● Limitations (not a substitute for medicine)
● Possible interactions
8.2 Dispense product.
3. DOCUMENTATION AND RECORDING
9.0 Supplement recommendation log
9.1Adverse reaction documentation
4. REVIEW AND APPROVAL
Prepared by: Approved by:
Muhammad Raffi T. Gadi Juanito Carlo VI Deita, RPh, PharmD
SOP # PHC-202-SOP-0
4
Version # 1
Dispensing of
Dangerous / Effective Date February 27,
Regulated Drugs 2026
Page # 1 of 1 Last Reviewed/ February 27,
Updated 2026
Standard Operating Procedure
1. PURPOSE AND SCOPE
1.0 Purpose
To ensure strict compliance with legal and regulatory requirements in dispensing
dangerous drugs.
2.0 Scope
Applies exclusively to licensed pharmacists authorized to dispense regulated
substances.
2. DETAILED PROCEDURE
3.0 Reception and Validation
3.1 Receive the Special DOH Prescription (yellow prescription).
3.2 Validate required prescription elements (per your provided list):
3.2.1 Date of prescription
3.2.2 Patient complete name and address
3.2.3 Prescriber complete name, address, telephone number
3.2.4 Prescriber PRC Registration No., PTR No., and current S-2 License No.,
signature
3.2.5 Brand and generic name of drug
3.2.6 Total number of units in words + Roman numeral in parentheses
3.2.7 Directions for use and the words “NON-REPETITION”
3.3 Confirm prescription format requirement: 1 original + 2 duplicates (RA 9165
notes).
3.4 Screen for alterations/erasures; if suspicious, do not dispense and proceed to
4.4.
4.0 Interpretation
4.1 Verify clinical appropriateness: dose, directions, duration, and patient risk
factors.
4.2 Confirm the regulated product matches the prescription exactly (generic/brand,
strength, dosage form).
4.3 Confirm prescription limits per applicable rules (your notes list: cancer patients
vs ordinary circumstances—apply your class/IRR limits if provided by instructor).
4.4 If any discrepancy, suspicious transaction, or unclear instruction:
4.4.1 Withhold dispensing
4.4.2 Contact prescriber for clarification
4.4.3 Document action as “clarified/denied/withheld”
4.4.4 If suspicious order, follow establishment duty to check and notify suspicious
transactions (per your notes).
5.0 Preparation and Labeling
5.1 Retrieve stock from secured storage with pharmacist-only access.
5.2 Check product integrity, expiry, and batch/lot number.
5.3 Count/prepare exact quantity with witness check if required by policy.
5.4 Label with:
5.4.1 Patient name
5.4.2 Generic name (and brand if needed)
5.4.3 Strength/dosage form
5.4.4 Directions for use (as written)
5.4.5 Cautionary labels (e.g., keep out of reach, avoid sharing)
5.5 Ensure the dispensed quantity does not exceed what is authorized on the
special prescription.
6.0 Final Checking
6.1 Perform final verification against prescription: correct patient, drug, strength,
quantity, label, and legality of prescription details.
6.2 Ensure copies are properly handled (see 7.2) and records are ready for
inspection.
7.0 Recording and Documentation
7.1 Record transaction in the Dangerous Drugs register/logbook consistent with RA
9165 Section 40, including the following (as in your notes):
7.1.1 Pharmacist license number and address
7.1.2 Supplier/manufacturer/importer/wholesaler details for acquisitions (for
inventory traceability)
7.1.3 Quantity and name of dangerous drugs acquired
7.1.4 Date of acquisition
7.1.5 Buyer name, address, and community tax certificate number (if required by
your notes/records)
7.1.6 Serial number of prescription and prescriber identity
7.1.7 Quantity and name of drug sold/delivered
7.1.8 Date of sale/delivery
7.2 Handling of prescription copies (per your notes):
7.2.1 Retain the original in the pharmacy for 1 year from date of sale/delivery
7.2.2 Buyer retains one copy until drug is consumed
7.2.3 Prescriber retains the second copy
7.3 Update inventory balance immediately and record within required timeframe
(your notes: record within 24 hours).
7.4 Prepare for semi-annual submission: certified true copy of records covering 6
months forwarded within 15 days after end of June and December (as stated in your
notes).
7.5 Report discrepancies, loss, theft, or destruction per establishment duty list in
your notes.
8.0 Patient Counseling and Dispensing
8.1 Counsel patient on:
8.1.1 Exact dosing and strict adherence
8.1.2 Avoid sharing/transfer; legal and safety implications
8.1.3 Secure storage and disposal
8.1.4 Common serious warning signs requiring consultation (non-graphic,
safety-focused)
8.2 Dispense only after confirming patient understanding.
8.3 Remind patient that the prescription is NON-REPETITION (no refills unless
reissued by authorized prescriber).
Documentation and Recording (Traceability)
9.1 Dangerous Drugs register/logbook entries complete and updated.
9.2 Prescription originals retained securely for required period.
9.3 Inventory reconciliation files and discrepancy reports maintained.
9.4 Inspection readiness: registers available for authorized inspection per your
notes.
3. DOCUMENTATION AND RECORDING
9.1 Dangerous Drugs register/logbook entries complete and updated.
9.2 Prescription originals retained securely for required period.
9.3 Inventory reconciliation files and discrepancy reports maintained.
9.4 Inspection readiness: registers available for authorized inspection per your
notes.
6. REVIEW AND APPROVAL
Prepared by: Approved by:
Muhammad Raffi T. Gadi Juanito Carlo VI Deita, RPh, PharmD